Insights
Insights
18-Oct-17 Johnson & Johnson took a USD10 mn hit on its international knee implant business in the 2017 July-September quarter, which it blamed on price cuts in India. [image: ET Healthworld]
Read More
18-Oct-17 Prices of cardiac stents and knee implants in India have been cut by 70-80%, a result of government price caps, sounding alarm bells for international players and potentially undermining future foreign investments in the sector. [image: Times Now]
Read More
26-Sep-17 The Indian government has ordered knee implant makers and importers to continue to supply of all brands of the device they were marketing in India before the country's drug pricing regulator slashed prices by up to 69% in August. [image: ET Healthworld]
Read More